Yukitoshi Takahashi Selected Research

N-Methylaspartate (NMDA)

12/2020	Characteristics of internalization of NMDA-type GluRs with antibodies to GluN1 and GluN2B.
9/2020	Cryptococcus Meningitis Can Co-occur with Anti-NMDA Receptor Encephalitis.
8/2020	Limbic encephalitis with antibodies to N-methyl-D-aspartate (NMDA)-type glutamate receptor after allogeneic transplantation.
3/2020	A case of Kleine-Levin syndrome with positive anti-NMDA-type glutamate receptor antibodies.
9/2017	Dystonic Seizures and Intense Hyperperfusion of the Basal Ganglia in a Patient with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
5/2017	Ovarian teratoma development after anti-NMDA receptor encephalitis treatment.
11/2016	Encephalitis With Antibodies to GluN2B During Administration of Clozapine.
11/2016	Antibodies against peptides of NMDA-type GluR in cerebrospinal fluid of patients with epileptic spasms.
9/2016	[NMDA-GluR Subunit Antibody-Positive Encephalitis: A Clinical Analysis of Five Cases].
7/2015	Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yukitoshi Takahashi Research Topics

Disease

45	Encephalitis (Encephalitis, Rasmussen) 05/2022 - 08/2003
41	Seizures (Absence Seizure) 05/2022 - 03/2003
41	Epilepsy (Aura) 01/2022 - 03/2003
31	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2021 - 09/2005
13	Tuberous Sclerosis (Bourneville's Disease) 01/2021 - 01/2017
12	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2020 - 11/2008
9	Drug Resistant Epilepsy 01/2020 - 06/2003
9	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2020 - 01/2008
9	Brain Diseases (Brain Disorder) 07/2016 - 10/2005
7	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2021 - 01/2010
7	Leukocytosis (Pleocytosis) 09/2016 - 10/2007
6	Spasm (Spasms) 01/2022 - 07/2011
6	Neoplasms (Cancer) 01/2021 - 01/2007
6	Hyperammonemia 12/2019 - 09/2012
6	Ovarian Teratoma 05/2017 - 01/2007
6	Infections 08/2015 - 01/2004
6	Disease Progression 07/2015 - 09/2005
6	Status Epilepticus (Complex Partial Status Epilepticus) 07/2015 - 06/2003
6	Cerebellar Ataxia (Dysmetria) 10/2013 - 06/2003
5	Body Weight (Weight, Body) 01/2022 - 04/2015
5	Infantile Spasms (West Syndrome) 01/2022 - 05/2012
5	Partial Epilepsies (Epilepsy, Partial) 01/2020 - 07/2011
5	Epilepsia Partialis Continua 09/2011 - 08/2003
4	Autoimmune Diseases of the Nervous System 01/2021 - 07/2007
4	Angiomyolipoma 01/2020 - 01/2017
4	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 01/2017
4	Drug-Related Side Effects and Adverse Reactions 01/2018 - 02/2010
4	Ataxia (Dyssynergia) 03/2017 - 05/2007
4	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 04/2014 - 10/2012
3	Demyelinating Diseases (Demyelinating Disease) 05/2022 - 11/2014
3	Temporal Lobe Epilepsy 01/2022 - 06/2007
3	Myoclonus (Nocturnal Myoclonus) 10/2020 - 07/2007
3	Nervous System Diseases (Neurological Disorders) 10/2020 - 11/2013
3	Inflammation (Inflammations) 12/2018 - 07/2015
3	Teratoma (Teratoid Tumor) 05/2017 - 01/2010
3	Virus Diseases (Viral Diseases) 03/2016 - 03/2011
3	Relapsing Polychondritis 01/2015 - 12/2009
3	Meningoencephalitis 01/2014 - 01/2008
2	Focal cortical dysplasia of Taylor 01/2022 - 07/2021
2	CDKL5 deficiency disorder 04/2021 - 01/2017
2	Cognitive Dysfunction 01/2021 - 09/2014
2	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 09/2011
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 05/2017

Drug/Important Bio-Agent (IBA)

58	Glutamate Receptors (Glutamate Receptor)IBA 01/2021 - 06/2003
52	AntibodiesIBA 05/2022 - 06/2003
36	AutoantibodiesIBA 01/2021 - 01/2005
20	Anticonvulsants (Antiepileptic Drugs)IBA 07/2021 - 11/2006
17	N-Methylaspartate (NMDA)IBA 12/2020 - 01/2005
16	Carbamazepine (Tegretol)FDA LinkGeneric 12/2019 - 08/2005
16	Phenytoin (Dilantin)FDA LinkGeneric 12/2018 - 01/2011
14	trans-sodium crocetinate (crocetin)IBA 01/2021 - 01/2017
14	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018 - 07/2008
13	SteroidsIBA 01/2021 - 01/2004
13	Valproic Acid (Depakote)FDA LinkGeneric 01/2020 - 06/2003
12	Phenobarbital (Luminal)FDA Link 12/2019 - 06/2003
11	CytokinesIBA 10/2015 - 10/2008
10	NR2B NMDA receptorIBA 08/2010 - 08/2003
9	Methylprednisolone FDA LinkGeneric 01/2021 - 05/2007
8	Lamotrigine (Lamictal)FDA LinkGeneric 01/2022 - 09/2011
8	Pharmaceutical PreparationsIBA 01/2022 - 02/2010
8	Clobazam (HR 376)IBA 01/2020 - 06/2005
7	perampanelIBA 10/2021 - 01/2017
7	EpitopesIBA 09/2014 - 01/2005
6	Topiramate (Topamax)FDA LinkGeneric 01/2018 - 07/2010
6	Intravenous Immunoglobulins (IVIG)FDA Link 02/2017 - 01/2004
6	Proteins (Proteins, Gene)FDA Link 01/2014 - 07/2008
5	AmmoniaIBA 12/2015 - 09/2012
5	Glutamic Acid (Glutamate)FDA Link 12/2015 - 03/2011
5	Immunoglobulin G (IgG)IBA 04/2013 - 05/2007
4	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022 - 07/2013
4	stiripentolIBA 01/2020 - 11/2009
4	Cytochrome P-450 CYP2C19IBA 01/2020 - 01/2011
4	EnzymesIBA 12/2018 - 01/2012
4	Prednisolone (Predate)FDA LinkGeneric 02/2017 - 02/2008
4	Immunoglobulins (Immunoglobulin)IBA 07/2016 - 06/2005
4	ChemokinesIBA 10/2015 - 11/2014
4	HLA-B Antigens (HLA-B)IBA 04/2014 - 11/2008
4	erucylphosphocholineIBA 09/2011 - 01/2005
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2020 - 09/2014
3	Uridine Diphosphate (UDP)IBA 03/2017 - 06/2014
3	Tacrolimus (Prograf)FDA LinkGeneric 09/2016 - 11/2007
3	Cytochrome P-450 CYP2C9IBA 04/2015 - 01/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2013 - 10/2008
3	Zonisamide (Zonegran)FDA LinkGeneric 11/2013 - 08/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 10/2007
3	Immunoglobulin M (IgM)IBA 08/2009 - 09/2005
3	glutamate receptor delta 2IBA 02/2008 - 09/2005
3	Ionotropic Glutamate ReceptorsIBA 10/2007 - 09/2005
3	barbituric acid (barbiturate)IBA 10/2007 - 06/2003
2	Sirolimus (Rapamycin)FDA Link 01/2022 - 07/2021
2	rufinamide FDA Link 01/2022 - 01/2017
2	Oligoclonal BandsIBA 01/2021 - 01/2008
2	GlucocorticoidsIBA 01/2021 - 08/2014
2	AntigensIBA 09/2020 - 03/2008

Therapy/Procedure

50	Therapeutics 01/2022 - 03/2003
5	Immunotherapy 03/2020 - 07/2010
3	Ketogenic Diet 03/2018 - 07/2011
3	Aftercare (After-Treatment) 05/2017 - 09/2013
3	Artificial Respiration (Mechanical Ventilation) 01/2011 - 10/2005